Melanoma is the most recognisable skin tumour in gray horses. Dark nodules appear under the tail and around the anus, slowly grow in number and size, and in most horses cause few problems until they become large or spread. For the NAVLE you need to recognise the signalment and sites, know that surgery and intralesional chemotherapy are the main options, and describe cimetidine and the canine vaccine accurately.
Key facts
Melanoma at a glance- Species and system: horses; skin (melanocytic tumours).
- Signalment: most tumours are in gray horses whose coats turn gray or white with age; especially common in Lipizzaners, Arabians and Percherons, where up to 80% of gray or white horses may be affected.
- Onset: begin to develop at 3 to 4 years of age but are recognised in older horses.
- Sites: perineum and base of the tail most common, but any location including the parotid area.
- Behaviour: often multiple, coalescent, frequently pedunculated, black on cross-section; most are benign but invasive variants with metastatic potential occur.
- Treatment: surgical or cryosurgical removal; intralesional cisplatin or carboplatin and electrochemotherapy for large or inoperable masses.
What's inside
12 sections in the full guide- Key facts
- How the NAVLE tests this
- Cause and pathophysiology
- Clinical signs
- Diagnosis
- Differential diagnoses
- Treatment and management
- Prevention, control and public health
- Prognosis
- Quick review
- Test yourself
- References
The full guide also has 4 tables, 1 figure, 3 self-test questions and 7 references, available to NAVLE members.
Read the full study guide
The full guide is part of every NAVLE plan, with diagnosis and treatment tables, figures, a quick review and self-test questions. Start a free trial to try the question bank, or log in if you are already a member.